Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Status:
Completed
Trial end date:
2020-03-05
Target enrollment:
Participant gender:
Summary
Proof of concept, open-label single center study for the donation of HCV positive kidneys to
HCV negative patients, with preemptive, interventional treatment to prevent HCV transmission
upon transplantation.